@Soeren_Berlin Avatar @Soeren_Berlin Sören Creutzburg

Sören Creutzburg posts on X about $sgmo, $qure, company, $ntla the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence finance 16.83% stocks 14.85% cryptocurrencies 6.93% technology brands 5.94% currencies 3.96% countries 1.98% celebrities 0.99% social networks 0.99% exchanges 0.99%

Social topic influence $sgmo #4, $qure 11.88%, company 7.92%, $ntla #3, sandy 5.94%, update 5.94%, $lrmr 4.95%, $dtil 4.95%, $sln 4.95%, for the 4.95%

Top accounts mentioned or mentioned by @zinselmeyerb @mitchellreed09 @francaole @soerenberlin @04121959 @martingtobias @fda @oskarstocks @biotechanalysst @crunchyroll @uniqurenv @mvcinvesting @sciencemagazine @analysethat @meangenebio @stockwizard1959 @mattkovacsworld @geneinvesting @unionsteel2017 @sangamotx

Top assets mentioned uniQure N.V. (QURE) Intellia Therapeutics, Inc (NTLA) Smart Layer Network (SLN) Iovance Biotherapeutics, Inc. Common Stock (IOVA) Sarepta Therapeutics, Inc. (SRPT) AstraZeneca PLC (AZN) Tenaya Therapeutics, Inc. (TNYA) AltLayer (ALT) ArbitrageCT (ARCT) Nebius Group N.V. Class A Ordinary Shares (NBIS) Metagenomi Technologies, LLC (MGX) CRISPR Therapeutics AG (CRSP) Prime Medicine, Inc. (PRME) BEAM (BEAM)

Top Social Posts

Top posts by engagements in the last [--] hours

"$SGMO context matters. Yes - RS can often be put on a level with kiss of death because it usually means that the company does not expect to have anything else to push the SP above a required/attractive threshold for a foreseeable time The difference with Sangamo is that they do BUT I might come shortly after the delisting date so as always there are exceptions to the rule. I am the last one romanticising RS and dont necessarily see one coming but IF one were to come it makes sense to consider context. @Soeren_Berlin @MitchellReed09 Mitigating and soft-soaping a RS can be misleading and"
X Link 2026-02-13T13:20Z [----] followers, [----] engagements

"If the @FDA were to backtrack their black-label approval now on $SRPT Elevidys due to an unrelated Phase [--] death (SRP-9004)an event they were already fully aware of when granting the black-box label and clear path forwardthis would turn the agency into a total clown show. Scientifically and economically three realistic scenarios: [--]. Base Case (55% prob): FDA maintains Elevidys approval for ambulatory patients with the new black-box label intact. Implementation of the improved immune protocol (e.g. Sirolimus) reduces liver toxicity significantly. Annual sales stabilize at $1B supported by the"
X Link 2025-07-18T22:40Z [----] followers, 14.7K engagements

"I have absolutely no $SGMO expectations for todays $ALPMF presentation. Which historically is the optimal expectations framework you can only be positively surprised. $XBI $SGMO Astellas presentation at JPM Healthcare conference in [--] hours (2 hours after markets close). $XBI $SGMO Astellas presentation at JPM Healthcare conference in [--] hours (2 hours after markets close). $XBI"
X Link 2026-01-12T15:08Z [----] followers, [----] engagements

"As someone holding both across multiple portfolios I dont think better data is a thing here. Did you actually look at the $SGMO data Depth patient numbers and most importantly time on therapy. This isnt just slowing progression its showing meaningful functional improvement. $QURE is simply years behind in data quantity & maturity. And for Fabry specifically I see very limited upside by nature of their approach that asset is a dead birth to me. The real $QURE value is AMT-130 AMT-260 and AMT-162. AMT-130 alone already justifies a strong case. If AMT-260 also hits $800/share within [----] years"
X Link 2026-02-01T23:08Z [----] followers, [----] engagements

"Thats gonna be interesting: SpaceX just acquired xAI"
X Link 2026-02-02T21:55Z [----] followers, [----] engagements

"Thats how Elon is gonna offset xAI costs. Meanwhile OpenAI depends on $50B upward VC lifelines without any clear path towards profitability and or keeping pole position. Thats gonna be interesting: SpaceX just acquired xAI Thats gonna be interesting: SpaceX just acquired xAI"
X Link 2026-02-02T21:59Z [----] followers, [----] engagements

"Sangamo is not short on science. It is short on structure cadence and a credible capital strategy. That is a solvable problem but only if it is addressed directly and with clear fiduciary intent. http://x.com/i/article/2019181007421710337 http://x.com/i/article/2019181007421710337"
X Link 2026-02-05T00:01Z [----] followers, [----] engagements

"A shareholders ToDo for $SGMO executives https://t.co/1Urlf0p6bM https://t.co/1Urlf0p6bM"
X Link 2026-02-05T00:04Z [----] followers, [----] engagements

"@Oskarstocks @MitchellReed09 No - without"
X Link 2026-02-13T12:30Z [----] followers, [--] engagements

"Go broke was obviously hyperbole the real downside in 99% of cases isnt bankruptcy its getting bought for a tiny fraction of what Sangamo Therapeutics could unlock in [----]. Per its latest 10-Q http://x.com/i/article/2018041488836362240 http://x.com/i/article/2018041488836362240"
X Link 2026-02-02T17:10Z [----] followers, [----] engagements

"While I personally dont necessarily expect $SGMO news during the WORLD Symposium its certain we are going to hear news rather soon. My [----] outlook: https://t.co/QYM5QfRqKT https://t.co/QYM5QfRqKT"
X Link 2026-02-02T17:12Z [----] followers, [----] engagements

"$NKTR I've never seen any "discussion" ending very positively. The word itself indicates it's a sword with two sides. My latest "discuss" call was $LRMR meeting very flexible and novel frataxin concentration surrogate endpoints (positive) accompanied by heavy SAEs (negative) and study dropout that results in lower long-term n data of existing study base leading to delay and more dilutive funding (2x after stating in two different calls that it's not needed)"
X Link 2026-02-10T01:10Z [----] followers, [----] engagements

"RT @BiotechAnalysst: BREAKING $SGMO Nav1.7 gene tx for SFN Pain dose escalation is underway (4 sites activated) @ earnings will provide"
X Link 2026-02-12T14:58Z [----] followers, [--] engagements

"Even $IMUX starting the rocket before $SGMO 🚀🔥🥂🫶💪 🏦 Today #Immunic announced an oversubscribed #PrivatePlacement of up to USD [---] million to accelerate the transformation into a commercial-stage company Key elements: 🔹 Upfront proceeds of USD [---] million with potential for up to USD [---] million in additional proceeds 🔹 https://t.co/TsqhDLH4d9 🏦 Today #Immunic announced an oversubscribed #PrivatePlacement of up to USD [---] million to accelerate the transformation into a commercial-stage company Key elements: 🔹 Upfront proceeds of USD [---] million with potential for up to USD 200"
X Link 2026-02-13T13:54Z [----] followers, [----] engagements

"$SGMO As the stellar Fabry data apparently didnt reach BP ears Sandy decided to deploy part of the freshly raised dollars into a vintage music video hoping it might convert better than clinical efficacy. Desperate times call for creative capital allocation. #Satire #JustAJoke #TakeItWithHumor"
X Link 2026-02-12T23:10Z [----] followers, [----] engagements

"My top [--] biotech picks for [----] 🧬 (no particular order) [--]. $SGMO [--]. $DTIL [--]. $PMN [--]. $SLN [--]. $PRQR [--]. $TNYA [--]. $IOVA [--]. $QURE [--]. $ACHV [--]. $ALT [--]. $ARCT [--]. $CYBN [--]. $SLS [--]. $RCKT [--]. $IMUX [--]. $BTAI [--]. $FATE [--]. $PDSB [--]. $AUTL [--]. $EQ Bonus: $NTLA High risk. High volatility. High upside. https://twitter.com/i/web/status/2005395911799959790 https://twitter.com/i/web/status/2005395911799959790"
X Link 2025-12-28T21:50Z [----] followers, 20.1K engagements

"Such a hidden incoming champion that even I always forget to include it: $MGX"
X Link 2025-12-29T00:53Z [----] followers, [----] engagements

"Wait until people finally start to discover and love the wondrous world of $SGMO ZFs Might be the day that starts everything Remember 2/13/26 as the day people realized CRISPR therapies can actually make money. Thanks to $CRSP for finally ramping some. $NTLA $PRME $BEAM https://t.co/UlajS9v17y Might be the day that starts everything Remember 2/13/26 as the day people realized CRISPR therapies can actually make money. Thanks to $CRSP for finally ramping some. $NTLA $PRME $BEAM https://t.co/UlajS9v17y"
X Link 2026-02-13T17:05Z [----] followers, [----] engagements

"This feels criminal BREAKING: Netherlands House of Representatives approves 36% tax on unrealized capital gains in stocks crypto and bonds. BREAKING: Netherlands House of Representatives approves 36% tax on unrealized capital gains in stocks crypto and bonds"
X Link 2026-02-14T00:01Z [----] followers, [----] engagements

"@Crunchyroll People choosing Ruka be like:"
X Link 2025-09-06T22:11Z [----] followers, [----] engagements

"$SGMO next I have no words. $NBIS just crossed $100/share. More than the money the feeling of seeing our research pay off is truly priceless. Thank you all for the kind DMs and support 🙏🏻 https://t.co/cvjqKdulmv I have no words. $NBIS just crossed $100/share. More than the money the feeling of seeing our research pay off is truly priceless. Thank you all for the kind DMs and support 🙏🏻 https://t.co/cvjqKdulmv"
X Link 2025-09-08T21:31Z [----] followers, [----] engagements

"$SGMO ST-503 updates 👉 On track. 👉 First human gene therapy trial for neuropathic pain (beyond iSFN niche targeting a $600B/year pain market - $100B + purely meds) 👉 Likely first data readout by late Dec / early Jan. Will be kind of a first platform validation moment that will flip the narrative fast. https://ctv.veeva.com/study/safety-and-tolerability-study-of-st-503-for-small-fiber-neuropathy-associated-refractory-pain https://ctv.veeva.com/study/safety-and-tolerability-study-of-st-503-for-small-fiber-neuropathy-associated-refractory-pain"
X Link 2025-09-08T21:35Z [----] followers, [----] engagements

"The $SGMO ST-503 poster presented in Berlin is a reminder of the massive potential here. Motivated me to put together a new deep dive on why Pain alone is a platform-validation catalyst and will likely re-rate the whole company. 👉 https://x.com/Soeren_Berlin/status/1965469151159259177 https://t.co/jxqfos9iRm https://x.com/Soeren_Berlin/status/1965469151159259177 https://t.co/jxqfos9iRm"
X Link 2025-09-09T17:44Z [----] followers, [----] engagements

"$SGMO As Ive said before Im no fortune teller. But after another post from the negativity queen and some others on the marketing piece today heres my take: A company going dark on newsletters for almost a year because of other problems Understandable. Then suddenly breaking silence with a Fabry marketing piece after [--] months of nothing To me thats bullish. Marketing & social media in biotech is unnecessary luxury. This has zero impact on finding a partner. No. One. Gives. A. Fuck. So why drop it now If you post like that after going dark that long and its something known you know that people"
X Link 2025-09-11T02:16Z [----] followers, [----] engagements

"$SGMO Again I feel obligated to communicate my thoughts here: The only bad thing about the CFO transition is the panic reaction driven by retail fear-mongering. Stock wouldnt even move without panic makers. No one but black painters like Shortseller or Feuerstein shine negative light on this CFO news and they have their own missions (panic & clickbait). This CFO leaving = bullish. She wasnt a good fit for Sangamo. Sangamo needs a deal closer. If mgmt had paired this news up with a new CFO already stock would be UP big time. SGMO is still sitting at the bottom with: - [--] commercial-ready"
X Link 2025-09-12T00:22Z [----] followers, [----] engagements

"$SGMO what a turnaround. Not even a dip left for Europeans when the market opens From -22% AH to green. People realized a lot faster than I expected that this CFO news is actually bullish"
X Link 2025-09-12T02:15Z [----] followers, [----] engagements

"$SGMO [--] days ago Sandy wrote: We are working diligently to advance the partnership 1) Not using the term deal anymore. 2) Not talking about a partner but about advancing the partnership. 3) Talking about advancing the partnership requires having a partner to advance the partnership with. Hes usually quite selective with words. But everyone is entitled to their own interpretation. Just my [--] cents"
X Link 2025-09-12T12:34Z [----] followers, 15.3K engagements

"$SGMO Considering we just defended another communication highlight and its Friday we deserve a nice meme heading into the weekend. So heres one for the tribe:"
X Link 2025-09-12T21:18Z [----] followers, [----] engagements

"Doing everything but improving the core: - customer support - stock & ETF offerings - AH trading options - I like Trade Republic due to lack of better UI/IX alternatives here but this lack of Gen Z convenience competition seems to create lack of urgency. Look at what your idol Robin Hood is doing and the speed at which they move. Please. It was fully unnecessary to go into what e.g. is already doing here at least at this point of time Focus on fixing and improving your foundation that people originally came for and factually still stay for https://www.investnao.com https://www.investnao.com"
X Link 2025-09-14T16:46Z [----] followers, [----] engagements

"Who else is looking forward to [--] more $SGMO surprise bags in the week to come 🔥🚀"
X Link 2025-09-14T17:13Z [----] followers, [----] engagements

"$SGMO ST-503 Update MGH Boston site on track to be the first to open recruitment after receiving IRB approval. Sangamo will also offer financial support for travel costs for participants"
X Link 2025-09-15T13:55Z [----] followers, [----] engagements

"My face while eating & scanning for any new $SGMO news"
X Link 2025-09-15T20:08Z [----] followers, [----] engagements

"$SGMO update on MINT progress https://www.linkedin.com/posts/sangamo-therapeutics_genomicmedicine-genomeengineering-integrases-activity-7373728608663724032-Ld4tutm_source=share&utm_medium=member_ios&rcm=ACoAABWrWWwBpLaQbYUsLYI45kGJUaMwiAF1Jsc https://www.linkedin.com/posts/sangamo-therapeutics_genomicmedicine-genomeengineering-integrases-activity-7373728608663724032-Ld4tutm_source=share&utm_medium=member_ios&rcm=ACoAABWrWWwBpLaQbYUsLYI45kGJUaMwiAF1Jsc"
X Link 2025-09-16T15:09Z [----] followers, [----] engagements

"$SGMO 35% targeted integration at TRAC basically means Sangamo managed to get [--] out of [--] T-cells to insert a therapeutic gene exactly in the right genomic parking spot (TRAC locus). Thats quite strong already. Its probably easier to put it into some comparison context: VIRAL CAR-T today get similar numbers (3080% CAR+ cells) BUT its random insertions some cells crank expression some barely some land in risky places. It works but its chaotic. CRISPR/HDR can target TRAC but usually without selection youre at 520%. You can enrich or use tricks but its costly and stresses cells. Sangamos MINT"
X Link 2025-09-16T16:54Z [----] followers, [----] engagements

"$SGMO is the biggest FOMO play Ive ever experienced. Its like dating the hottest person on earth for an eternity but never actually sleeping with each other. Not once. Pure edging day after day. You cant leave because you know it could finally happen any moment. Rationally it feels like youre always getting closer. Meanwhile you look around and see others falling in love growing thriving and you keep holding on because deep down you know: theres no one better. One day itll click and when it does everyone will look at this couple in envy and disbelief wondering how that this turd bagged that"
X Link 2025-09-16T22:03Z [----] followers, [----] engagements

"$SGMO There is [--] informational value in that article. Nothing new. How can they call themselves journalist. Quite a disgrace. For all the peeps that dont have a Fraudstein Stats clickbait subscription: Here is what they called article and news: Why Sangamo is facing an uphill challenge Sangamo Therapeutics hasnt convinced a pharma company to buy its experimental gene therapy for Fabry disease after two years of trying. Heres why a deal may never happen: Fabry is a rare and serious lysosomal storage disease but currently approved treatments enzyme replacements and a protein chaperone treatment"
X Link 2025-09-18T11:43Z [----] followers, [----] engagements

"$SGMO message from Sandy 🚀 Thanks Wizard"
X Link 2025-09-18T12:34Z [----] followers, 12.3K engagements

"I like to use the term unicorn cockroach for myself. But after [--] years no one deserves it more than $SGMO. Some bashers tried to use their reach today to push the unicorn cockroach $SGMO down. After a 10-minute -8% drop it didnt just bounce back to [--] it went +8%"
X Link 2025-09-18T16:33Z [----] followers, [----] engagements

"I keep thinking whats gonna hit first $LRMR data $QURE data or the $SGMO deal announcement Gonna add from cash. Plan: deploy 60/40 Monday morning into both $LRMR + $QURE ride whoever reports first rotate into the other before their news then funnel profits from both into topping up $SGMO. Who knows maybe Sandman will screw my plan and announce a deal before any of these report"
X Link 2025-09-20T03:27Z [----] followers, [----] engagements

"$QURE BOOM - the bet paid off I keep thinking whats gonna hit first $LRMR data $QURE data or the $SGMO deal announcement Gonna add from cash. Plan: deploy 60/40 Monday morning into both $LRMR + $QURE ride whoever reports first rotate into the other before their news then funnel profits from I keep thinking whats gonna hit first $LRMR data $QURE data or the $SGMO deal announcement Gonna add from cash. Plan: deploy 60/40 Monday morning into both $LRMR + $QURE ride whoever reports first rotate into the other before their news then funnel profits from"
X Link 2025-09-24T12:39Z [----] followers, [----] engagements

"I love when Martin is pumping my stocks Still waiting for the day $SGMO gets the same or more appreciation. That day is coming and sooner rather than later. FDA has no choice but approve $QURE drug. drug could do $2B in revenue easily - 5x bare minimum from $35 FDA has no choice but approve $QURE drug. drug could do $2B in revenue easily - 5x bare minimum from $35"
X Link 2025-09-24T13:29Z [----] followers, [----] engagements

"$QURE is my fifth 100%+ biotech bagger this year after $URGN $REPL and cross-portfolio $NTLA and $ARWR. $SGMO soon and its gonna be the best performing"
X Link 2025-09-24T16:58Z [----] followers, 32.7K engagements

"If anyone wonders why it feels so quiet at $SGMO with a deal so close remember: leaks are the exception not the rule. $QURE went from [--] to hero with no leaks just strong signals and SGMOs setup is eerily similar. Silence isnt weakness. Its the calm before the move. Another shout out to $QURE management. The price decline the past week or so had many concerned about possible leaks. As demonstrated by today's incredible data they run a very tight ship as it is obvious nothing leaked. Way to go @uniQure_NV Best management of bio ever. Another shout out to $QURE management. The price decline the"
X Link 2025-09-24T20:17Z [----] followers, [----] engagements

"So many delicious titles right now Quick excerpt of my cross-portfolio expectations for the days & weeks ahead: ✅ $QURE positive Huntingtons data (delivered) ✅ $PEPG positive DM1 data (delivered) Coming: $NTLA expecting data that confirms new SoC in ATTR-PN $LRMR expecting to hit flexible FXN primary $SGMO my hardest long ever Fabry partnership. This is gonna be the portfolio highlight. $OVID expecting good safety + positive GABA signal for P1 OV329 $IOVA betting on positive data for expansion into lung + strong ER"
X Link 2025-09-25T00:35Z [----] followers, [----] engagements

"$SGMO Just saw this email exchange floating around Stocktwits. Had a good laugh at the senders rant but as always Sandy comes back calm confident and steady: We are convinced by our technology and certain of our path forward. Deal incoming 🚀"
X Link 2025-09-25T00:56Z [----] followers, [----] engagements

"@mvcinvesting I will never get tired of repeating $SGMO"
X Link 2025-09-25T17:53Z [----] followers, [----] engagements

"Impressive work from Hsus team another editing architecture showing whats possible: Now imagine it anchored with $SGMO Zinc Fingers + integrase IP - more compact - more precise - more deliverable - again fully ownable The future of Sangamos CRISPR-free garden: 🌿 SAGE letters (point mutations) 🌿 MINT words (gene/exon rewrites) 🌿 BASIL paragraphs (repeat excisions inversions swaps) The complete editing spectrum highly specific highly compact highly proprietary. Some may want to beat me up for saying this but Im always looking beyond a Fabry deal. MINT = Modular Integrase SAGE = Sangamo"
X Link 2025-09-26T15:05Z [----] followers, [----] engagements

"$SGMO For anyone who hasnt seen this exchange screenshot on Stocktwits. Sanders seems to be determined to deliver our Christmas present rather soon soon"
X Link 2025-09-27T15:57Z [----] followers, [----] engagements

"I really dont like how a big chunk of guys here on Twitter always report their moves after the fact and surprise it always lines up perfectly with the outcome. Thats not transparent its inauthentic. The usual: ahhh ja forgot to mention I sold 80% pre-data or ahhh ja a few days ago I made Y one of my largest positions Come on. Be for real"
X Link 2025-09-29T13:25Z [----] followers, [----] engagements

"$SGMO I hope all the recent data losers $KALA $MLTX $IOBT $LRMR finally make people appreciate the stellar data + science $SGMO is delivering. Thats where the cash belongs"
X Link 2025-09-29T14:02Z [----] followers, [----] engagements

"Not getting tired of pointing out: all this $SGMO price noise is irrelevant peanuts compared to whats coming. First the Fabry deal thats the real first move. Then Pain data that alone could dwarf my wins in $NBIS (19.30 aBI) and $QURE (11.93 aBI). Those will look like nothing burgers in comparison. https://t.co/jxqfos9iRm https://t.co/jxqfos9iRm"
X Link 2025-09-29T15:33Z [----] followers, 10.7K engagements

"The $QURE 1Y chart looks insane right now. Fast forward a year if Sandy executes and Pain delivers $SGMO could be 23x bigger than that. Everyone will say it was so obvious. But these moments the mix of doubt and excitement most wont remember. Theyll fade and in hindsight feel almost transcendently unimaginable"
X Link 2025-09-29T19:17Z [----] followers, [----] engagements

"Had an exchange with $SGMO Sandy a few hours ago on those rumours and posts like these At this point he also knows very well that Im dissecting every single word and whatever is happening feels very close as hes even more cautious with language. I didnt directly push are we still advancing the partnership and he gave no hint either way. Instead he was frustrated about a post suggesting nothing until ER in November calling it out of context. Thats not nothing in fact if he was fine with that narrative the safest answer wouldve been silence or we dont comment on timing. Attacking the context"
X Link 2025-10-01T17:47Z [----] followers, [----] engagements

"$SGMO already Sunday and time is running so fast I feel excited. It feels like the quiet before ignition that strange calm right before everything shifts"
X Link 2025-10-05T01:33Z [----] followers, [----] engagements

"@Analysethat @meangenebio @StockWizard1959 Absolutely theyve got options and far more leverage than most people give them credit for"
X Link 2025-10-05T20:17Z [----] followers, [---] engagements

"Love how everyone and their mothers suddenly claims they were in $SPRB even though it was a $5M stock just [--] hours ago lol. For the record: I wasnt. Didnt even know them before noon. Congrats to the few who were actually long"
X Link 2025-10-06T18:50Z [----] followers, [----] engagements

"$SGMO think were in the endgame now. Soon is coming and I am looking forward to it. Im aware of at least three different people (including myself) who regularly exchange with Sangamo IR (Louise) or Sandy all sent messages between last Thursday and Monday and none have received a reply or reaction so far. Seems like its busy busy days Might be coincidence but thats a first"
X Link 2025-10-08T20:36Z [----] followers, 11.3K engagements

"This Car-Tregs data $SGMO shared tonight is a breakthrough and its a shame there is hardly a reaction here so far Its another piece of pioneer work and proof of principle and concept Sangamo just dropped this TX200 update (CAR-Tregs in kidney transplant) and its exactly the kind of first-in-human first-in-solid-organ signal weve been waiting for. Its probably what Sandy once envisioned and dreamt off and proving him right - especially alongside the CAR-Tregs Nobel Prize. Its legen.wait for itdary What the data says: - First in human first in vivo first in tissue: TX200 persists in blood 8"
X Link 2025-10-09T01:27Z [----] followers, 12.5K engagements

"I love $SGMO $SLN $PRQR $DTIL $PRQR platform biotech the molecular architects building the infrastructure of future medicine. The ones quietly rewriting the logic of life itself. My Suicide Squad Darlings: $SGMO Sangamo Therapeutics A league of its own. The godfather of programmable biology. Zinc Fingers before CRISPR was cool now the only company uniting Gene Therapy Regulation Editing Cell Engineering and Delivery into one living architecture. Five integrated domains: - Gene Therapy AAV-delivered functional genes (e.g. Fabry Hemo a ) - Gene Regulation ZF transcription factors turning genes"
X Link 2025-10-10T01:29Z [----] followers, [----] engagements

"Appreciated Franca :) Maybe Lady Destiny just wanted Sandy to wait for your return before announcing the $SGMO deal. @ZinselmeyerB also pointed out something interesting we havent mentioned yet theres a significant virtual conference coming up this week with EVERY major genetic medicine player participating every EXCEPT Sangamo. And beyond that its organized by Wainwright the very analyst house that gave $SGMO a $10 SP target. So every major genetic medicine player is participating except $SGMO at the event hosted by their biggest fanboy 🤔 Maybe something bigger coming this week"
X Link 2025-10-12T12:53Z [----] followers, [----] engagements

"$SGMO On Sept [--] Takeda filed a Form 6-K reversing [---] B ($5.6 B) of long-locked reserves back into retained earnings. Not cash raised but cash unlocked. Thats how you prep for something big: buybacks dividends or strategic M&A. Timings wild too same time Sangamo reshuffled its finance lead Could be coincidence. Could be setup. Either way the board just freed billions. Thanks for bringing it to my attention @04121959 https://fintel.io/doc/sec-takeda-pharmaceutical-co-ltd-1395064-6k-2025-september-25-20356-8030"
X Link 2025-10-13T14:31Z [----] followers, 12.6K engagements

"$SGMO In Germany we say Deal Dienstag (Deal Tuesday)"
X Link 2025-10-13T20:08Z [----] followers, [----] engagements

"$SGMO for anyone wondering why they werent at the conference. They were invited but declined. Bigger matters to finish perhaps @MattKovacsWorld @Soeren_Berlin @Franca_ole @ZinselmeyerB I talked to Sandy they seem to be skipping this one themselves. which makes me wonder 🤔 https://t.co/ZBS70vhvsZ @MattKovacsWorld @Soeren_Berlin @Franca_ole @ZinselmeyerB I talked to Sandy they seem to be skipping this one themselves. which makes me wonder 🤔 https://t.co/ZBS70vhvsZ"
X Link 2025-10-14T13:43Z [----] followers, [----] engagements

"$SGMO might deliver with delays but they deliver $SGMO ST-503 updates 👉 On track. 👉 First human gene therapy trial for neuropathic pain (beyond iSFN niche targeting a $600B/year pain market - $100B + purely meds) 👉 Likely first data readout by late Dec / early Jan. Will be kind of a first platform validation moment that https://t.co/ifeajJS64o $SGMO ST-503 updates 👉 On track. 👉 First human gene therapy trial for neuropathic pain (beyond iSFN niche targeting a $600B/year pain market - $100B + purely meds) 👉 Likely first data readout by late Dec / early Jan. Will be kind of a first"
X Link 2025-10-14T17:25Z [----] followers, [----] engagements

"Whoever still wonders what $SGMO ST-503 (aka Pain) is all about feel free to checkout my little writeup on it: https://x.com/soeren_berlin/status/1965469151159259177s=46 BREAKING $SGMO Pain trial just #started recruiting (means they #got the #funding to go on) https://t.co/jLINdDtjXs now we wait for the big PR . https://x.com/soeren_berlin/status/1965469151159259177s=46 BREAKING $SGMO Pain trial just #started recruiting (means they #got the #funding to go on) https://t.co/jLINdDtjXs now we wait for the big PR "
X Link 2025-10-14T18:30Z [----] followers, [----] engagements

"@Franca_ole Ah so thats why the $SGMO deal is taking so long someones gotta help the [--] exec team click Complete signing on DocuSign 😄"
X Link 2025-10-14T19:40Z [----] followers, [----] engagements

"This feed of $SGMO ungratefulness frustrates me. Look beyond. The fair rNPV/share potential of the first three targeted Tregs indications alone sits around $4/share right now which would likely unfold toward $19+ within three years. Pain fully risk-adjusted but modeled on aggressive indication expansion sits around $16/share today. Even at a very theoretical $200M dilution halving those targets still leaves massive upside. And thats without accounting for anything beyond Pain and the three CAR-Tregs indications (TX200 MOG IL-23R). The Tregs data was a huge win another proof of principle. It"
X Link 2025-10-16T19:33Z [----] followers, [----] engagements

"When it comes to Big Pharma its not that they dont see $SGMO s value its timing optics and validation. If I were a Big Pharma executive with a Martin Shkreli mindset Id be just as relaxed about recognizing value like this. Its part of the game. While the rule of dumb applies most cant see the forest while standing in hectares of trees the few who do recognize it only act when they must. And thats exactly how this game works. There are games within games everywhere. Sandy surely doesnt want to sell and he doesnt need to. He wants to earn and develop the fruits of his work. Everything Sangamo"
X Link 2025-10-16T20:42Z [----] followers, [----] engagements

"Sorry Ive had little time to post lately just wanted to drop a quick update: I added fresh cash to my $SGMO position yesterday and again today waiting for more to arrive. Its coming. 🚀"
X Link 2025-10-21T23:11Z [----] followers, [----] engagements

"Is this gonna be THE week for $SGMO $IOVA and $AUTL 👀🤓"
X Link 2025-10-26T14:47Z [----] followers, [----] engagements

"*I dont want to feel Schadenfreude I still had 5% positions in four portfolios pre-dump but somehow @GeneInvesting made me feel exactly that. Karma really is a bitch. Wheres your stock now Anything else to say about $SGMO Also you should probably be investigated you guessed those news just minutes before they hit We all know its part of the game but come on dont be stupid enough to post it online wth. P.S. might add to my $NTLA position on this later. $NTLA ripped into half $NTLA ripped into half"
X Link 2025-10-27T12:08Z [----] followers, [----] engagements

"What else should I say on $NTLA than $SGMO In Zinci Digito Credimus. Per dilutionem fortitudinem invenimus. Per silentium fidem probamus. Et cum pactum venit gloria infinita erit. Sangamo est lux Sandy est prophetia et nos sumus electi 🤣🫶"
X Link 2025-10-27T12:14Z [----] followers, [----] engagements

"Go $SGMO $SLN $PMN $DTIL $IOVA $CYBN $NTLA I used to see them as a safe haven and a low-hanging fruit in biotech and boring people prayed on them. Today proves again: theres no such thing as a safe haven in biotech and Cathie Wood remains the ultimate anti-signal. So Id rather go big and bold for max returns. The rewards are exponentially higher and the risks are basically the same just with a way better risk/reward ratio. Nothing beats my love for my lovely ugly underdogs. I love $SGMO $SLN $PRQR $DTIL $PRQR platform biotech the molecular architects building the infrastructure of future"
X Link 2025-10-27T12:31Z [----] followers, [----] engagements

"$SGMO Very interesting. Looks like they focused on accelerated generation of outcomes specifically pain-reduction signals in addition to broadening the label from iSFN to SFN and accelerating recruitment likely leading to a higher n faster and as such data of actual scientific value. BOOOM: HUGE $SGMO Pain trial update: Its now a #Phase2 Data not [--] but [--] weeks https://t.co/soNMk3Xcnd BOOOM: HUGE $SGMO Pain trial update: Its now a #Phase2 Data not [--] but [--] weeks https://t.co/soNMk3Xcnd"
X Link 2025-10-28T13:36Z [----] followers, 10.4K engagements

"I assume $SGMO to disclose this rather soon they wouldnt have shortened the primary outcome window unless they were confident the FDA was already aligned on it. Pain as an endpoint is relatively straightforward Id say you can tell pretty fast whether its working or not. So for efficacy the two key metrics are likely: [--]. Pain reduction at [--] weeks (PI-NRS) [--]. Reduction in Nav1.7 activity or expression Possibly also interesting though more indirect: [--]. Reduced pain medication use by [--] weeks For me Number [--] (Nav1.7 reduction) is the most interesting since its objective and mechanistically tied"
X Link 2025-10-28T22:33Z [----] followers, [----] engagements

"$SGMO As anticipated. Ready to rumble 🚀 So as bio rightly said: stfu on rs. https://investor.sangamo.com/static-files/9b25ed7b-8bf6-4b22-aedd-ef942e922b83 On October [--] [----] $SGMO received a letter (the #Extension #Notice) from The Nasdaq advising that the Company has been #granted a 180-day #extension or until April [--] [----] to regain compliance with the requirement tomaintain a minimum bid price of $1.00 per share now STFU RS https://investor.sangamo.com/static-files/9b25ed7b-8bf6-4b22-aedd-ef942e922b83 On October [--] [----] $SGMO received a letter (the #Extension #Notice) from The Nasdaq"
X Link 2025-10-29T20:26Z [----] followers, [----] engagements

"$SGMO Temporary IT Support position filled. Once hes fully onboarded his main task will be helping finalize the deal via DocuSign. He already managed to log into the account signature next. Louise pulled him away halfway through scrolling to the signature section to show him the cafeteria first #SometimesWeNeedAJoke $SGMO temporary jobs gone . https://t.co/kcvp7EUoUQ $SGMO temporary jobs gone . https://t.co/kcvp7EUoUQ"
X Link 2025-10-30T12:11Z [----] followers, [----] engagements

"$SGMO $sgmo https://t.co/EEnCNi4DXz $sgmo https://t.co/EEnCNi4DXz"
X Link 2025-10-30T20:09Z [----] followers, [----] engagements

"$SGMO 👀 @UnionSteel2017 An $SGMO earnings call before market open 5:30 a.m. in San Francisco. Analysts have to read the release before that. That timing is highly unusual its never been like this before with @SangamoTx News from Europe or Asia in the night before https://t.co/7QpKfKIEjx @UnionSteel2017 An $SGMO earnings call before market open 5:30 a.m. in San Francisco. Analysts have to read the release before that. That timing is highly unusual its never been like this before with @SangamoTx News from Europe or Asia in the night before https://t.co/7QpKfKIEjx"
X Link 2025-10-30T20:12Z [----] followers, [----] engagements

"$SGMO Pre Q3 ER thoughts Partnership or Buyout incoming - Both $AZN and $SGMO have ER on the same day and Sangamos chosen time looks oddly specific (different from any previous call). Maybe to fit a partner from another continent 🌍 - $AZN has AAV9 and manufacturing capabilities (potentially used in Pain). - They own Alexion which already partners with Sangamo on ALS. - AstraZeneca is active in the lysosomal storage disease (LSD) space via Alexion directly aligning with Fabry. - $AZN is expanding aggressively into gene therapy & AI (see their recent $555M deal with Algen - Plus $AZN has $7.1B"
X Link 2025-10-30T22:24Z [----] followers, [----] engagements

"$SGMO $AZN Cant wait for the ER. $AZN is releasing data at 7:00 a.m. Berlin time and starting their call at 2:00 p.m. $SGMO starts their call at 2:30 p.m. Berlin time releasing data shortly before Universe decided to handicap me Ill be at the airport boarding a flight at 2:50 p.m. So Ill have to digest everything on the go juggling [--] portfolios and trying to post updates at the same time"
X Link 2025-11-01T22:42Z [----] followers, 10.5K engagements

"$SGMO my realistic pre-ER odds (Nov 6) - Fabry partnership (40%) cash + co-dev; Alexion/AZN fits Fabry + rare-disease infra - Platform deal (25%) capsids (SIFTER/STAC) MINT Tregs or ZF licensing; upfront keeps lights on - Buyout (10%) Never say never but feels unlikely - No deal (25%) cash tight so constantly under dilution risk $SGMO $AZN Cant wait for the ER. $AZN is releasing data at 7:00 a.m. Berlin time and starting their call at 2:00 p.m. $SGMO starts their call at 2:30 p.m. Berlin time releasing data shortly before Universe decided to handicap me Ill be at the airport boarding a flight"
X Link 2025-11-02T00:44Z [----] followers, [----] engagements

"Just loading up more $QURE Easiest turnaround prediction since $SRPT"
X Link 2025-11-03T13:32Z [----] followers, [----] engagements

"$SRPT people are panic-selling on a PMO study that everyone already knew wouldnt meet its primary. Zero surprise here. Theyll still file for approval and theyll likely get it anyway. Prasad wont be around to influence the decision this time. His second ousting - end of the year maybe spring but its coming sooner rather than later. Either way PMOs arent the future of this company. Mr. Markets wrong again"
X Link 2025-11-03T21:23Z [----] followers, 14.4K engagements

"This start to the week makes me all the more curious about the $SGMO ER. Is $SGMO gonna be the joker at the end 👀🤓"
X Link 2025-11-03T23:42Z [----] followers, [----] engagements

"Me at the airport be like $SGMO"
X Link 2025-11-06T12:59Z [----] followers, [----] engagements

"$SGMO - this nothingburger is the second best thing we could have hoped for. No cash raise means deal progressing as planned"
X Link 2025-11-06T13:16Z [----] followers, [----] engagements

"$SGMO peoples retarded reaction in no news is the only thing annoying to me so far"
X Link 2025-11-06T13:19Z [----] followers, [----] engagements

"Arrived in the accommodation and run through the update. I quite like @Franca_ole summary for $SGMO: nothing changed (in terms of cash) everything else progressed positively. More cash than expected. No further atm or other fundraising and everything aligning for the Fabry deal still. Its inevitable. Other smaller deals for capsids and MINT are also being advanced. [----] is gonna be THE year for $SGMO Lots of people are hating I dont understand the retarded reaction. Just sell if you cant trust the process. I take the little dip and keep accumulating. Every week its down is a week I can keep"
X Link 2025-11-06T20:44Z [----] followers, [----] engagements

"@MartinGTobias @MartinGTobias - cool initiative. Tested and got an error when clicking on get free review - email used: scr@anyjoi.com"
X Link 2026-01-08T23:39Z [----] followers, [---] engagements

"DocuSign feels like a 12-year-old PHP app that accidentally became a public company. Slow. Bloated. Garbage. UX from [----]. Ive seen better performance from a PHP side project I wrote as a teenager. $DOCU still exists because people and especially lawyers hate change not because its good. https://twitter.com/i/web/status/2010725183477232012 https://twitter.com/i/web/status/2010725183477232012"
X Link 2026-01-12T14:46Z [----] followers, [----] engagements

"@BAMBossie81 Missing $SLN (deal or acquisition due similar to Sangamo) $DTIL (multiple key data points and likely partnership incoming)"
X Link 2026-01-21T18:21Z [----] followers, [---] engagements

"$SGMO $LSTA was eternally silent and at all time lows before announcing its acquisition out of nowhere"
X Link 2026-01-27T21:00Z [----] followers, [----] engagements

"YTD performance of my [----] biotech picks (as of 29.01.2026 AH) 🧬📊 📈 Pick stats so far: Avg YTD: +6.2% (21 stocks) Median YTD: +2% Hit rate: [--] / [--] positive (52%) Best: $PMN +77% Worst: $AUTL -27% Range: +77% -27% 🟢 Top performers: $PMN +77% $NTLA +53.7% $ALT +41.8% $FATE +23.1% $ARCT +20.2% $PDSB +18.0% $IMUX +14.2% 🟡 Flat / noise: $SLS +5.2% $BTAI +5.0% $RCKT +2.0% $IOVA +0.7% 🔴 Down YTD (ordered): $QURE -3.8% $DTIL -4.8% $TNYA -7.2% $EQ -9.7% $ACHV -12.3% $SGMO -13.4% $CYBN -15.7% $SLN -17.6% $PRQR -19.8% $AUTL -27.1% My top [--] biotech picks for [----] 🧬 (no particular order) [--]. $SGMO"
X Link 2026-01-29T02:15Z [----] followers, [----] engagements

"$SGMO planned to put out a PR today but new position still unfilled and Louise called in sick intern still fighting Gemini over tone so it might slip to AH or next days or weeks In the meantime Sandy shared the good news with his neighbours. Decentralised communication strategy hoping for organic distribution. #TakeItWithHumor #joke https://twitter.com/i/web/status/2016943764657283250 https://twitter.com/i/web/status/2016943764657283250"
X Link 2026-01-29T18:37Z [----] followers, [----] engagements

"@RNAiAnalyst Giant rug pull would have required news prior. https://x.com/soeren_berlin/status/2014710335073034354s=46 @RNAiAnalyst https://t.co/NOHzdB1QjU https://x.com/soeren_berlin/status/2014710335073034354s=46 @RNAiAnalyst https://t.co/NOHzdB1QjU"
X Link 2026-01-29T18:54Z [----] followers, [----] engagements

"At least the bio Squid Game pick on my second account is already performing Whoever figures out the account and the pick unlocks the next $SGMO write-up on Monday"
X Link 2026-01-30T20:32Z [----] followers, [----] engagements

"@HarryStebbings Finally. BA972"
X Link 2026-02-02T18:50Z [----] followers, [----] engagements

"@MartinGTobias I also feedbacked Boardy to look at your tool and build a matching VC counterpart - they seemingly did https://www.linkedin.com/posts/andrewdsouza_while-other-ais-were-hanging-out-on-moltbook-activity-7424143478940491777-BIaGutm_medium=ios_app&rcm=ACoAABWrWWwBpLaQbYUsLYI45kGJUaMwiAF1Jsc&utm_source=social_share_send&utm_campaign=copy_link https://www.linkedin.com/posts/andrewdsouza_while-other-ais-were-hanging-out-on-moltbook-activity-7424143478940491777-BIaGutm_medium=ios_app&rcm=ACoAABWrWWwBpLaQbYUsLYI45kGJUaMwiAF1Jsc&utm_source=social_share_send&utm_campaign=copy_link"
X Link 2026-02-02T19:32Z [----] followers, [---] engagements

"https://x.com/pawcio2009/status/2013099271977898100s=46 #Biopick2026 wk2. $IBRX goes into the lead last weeks leader $zntl drops out of top [--] 👇 [--]. $ibrx +173% 🚀 [--]. $eras +168% [--]. $alms +166% Individual leaders: [--]. @elijahwc (ibrx) [--]. @nbconsulting (ibrx) [--]. @moleriks (eras) Full Standings: https://t.co/ahoY4G83Z1 https://x.com/pawcio2009/status/2013099271977898100s=46 #Biopick2026 wk2. $IBRX goes into the lead last weeks leader $zntl drops out of top [--] 👇 [--]. $ibrx +173% 🚀 [--]. $eras +168% [--]. $alms +166% Individual leaders: [--]. @elijahwc (ibrx) [--]. @nbconsulting (ibrx) [--]. @moleriks (eras) Full"
X Link 2026-01-30T20:45Z [----] followers, [----] engagements

"https://x.com/jy201506/status/2017457014322954655s=46 @Soeren_Berlin ok found it. i guess the financing news prob got leaked a few days prior to the public disclosure. https://t.co/QAF27tWSCs https://x.com/jy201506/status/2017457014322954655s=46 @Soeren_Berlin ok found it. i guess the financing news prob got leaked a few days prior to the public disclosure. https://t.co/QAF27tWSCs"
X Link 2026-01-31T12:17Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing